Sandoz Group AG
SDZ
Rank in Stocks
#581
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Share Price
$96.01
Market Cap
$41.54B
Change (1 day)
0.82%
Change (1 year)
58.65%
Country
CH
Trade Sandoz Group AG (SDZ)
Category
Healthcare
EPS for Sandoz Group AG (SDZ)
EPS as of 2026 TTM: 0
According to Sandoz Group AG latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Sandoz Group AG from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2025 | $2.12 | 0.00% |
| 2024 | 0.00 | -100.00% |
| 2023 | $0.18 | -90.86% |
| 2022 | $1.97 | 2.60% |
| 2021 | $1.92 | 102.11% |
| 2020 | $0.95 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
